Join
Live feed
·
INSIDERFilingvia Quantisnow
ReShape Lifesciences Inc. logo

SEC Form 4: Stankovich Thomas was granted 364,756 shares and sold $62,938 worth of shares (372,113 units at $0.17), decreasing direct ownership by 2% to 325,404 units

ByQuantisnow·Wall Street's wire, on your screen.
RSLS· ReShape Lifesciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RSLS (ReShape Lifesciences Inc.) and more on Quantisnow.

SEC Form 4: Stankovich Thomas was granted 364,756 shares and sold $62,938 worth of shares (372,113 units at $0.17), decreasing direct ownership by 2% to 325,404 units | Quantisnow